Pathology of dimethylhydrazine (DMH)-induced vascular neoplasias and their comparison to AIDS-associated Kaposi's sarcoma (KS) (Meeting abstract). NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Pathology of dimethylhydrazine (DMH)-induced vascular neoplasias and their comparison to AIDS-associated Kaposi's sarcoma (KS) (Meeting abstract).

Anticancer Res; 12(6A):1785 1992. Unique Identifier : AIDSLINE ICDB/93696203
Madarnas P; Nigam VN; Naik R; Turgeon R; Dube M; Benrezzak O; Dept. of Pathology, Faculty of Medicine, Universite de; Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada


Abstract: KS is a progressive vascular condition presenting itself as an indolent cutaneous lesion in its classical form and with an aggressive visceral and cutaneous pathology in AIDS patients. KS occurs in epidemic proportions in HIV+ homo- and bisexual men in North America and Europe. The classical form is endemic and a major cancer in Africa. Spontaneous occurrence of malignant blood vessel neoplasms in both animals and humans is rare. DMH is one of the few carcinogens capable of inducing blood vessel neoplasms. The objective of our research was to see how the presentation and evolution of angiosarcomas in mice compares with the reported evolution of KS in HIV+ men. We also undertook this research to obtain an experimental animal model of AIDS-related KS. From various and subsequent experiments, we produced angiosarcoma lesions in male mice of several strains: in 39 CD1; 22 DBA/2 and 116 C57BL/6 (totaling 177 animals). All these animals had received sc 20 mg/kg of body wt of DMH once a week for 30-40 wk, depending on the experiment. All animals underwent gross and macroscopic examination to establish the number of lesions and their topography. 120 animals presented only one single lesion, 39 had two lesions and in 18, 3 or more lesions were found. An effort has been made to establish the topography of the primary sites and the pattern of their progression and spread as well as the pathological features of the early changes observed in vessels. The pattern of lesion distribution, when DMH is injected sc, contrasts with that of oral administration. Most primary lesions were found in the pelvic region and lower retroperitoneum. While low-grade lesions remain localized, the high-grade malignancies spread to other parts of the body (kidney, liver or lungs). An angiosarcoma cell line has been developed by tissue culture opening new areas for research. Some of the low-grade lesions observed in animals reproduce the histological features of the HIV-associated KS. The histology of the lesions developed in the immune-suppressed animals does not differ significantly from those of the other groups.
Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS/PATHOLOGY Animal *Dimethylhydrazines Hemangiosarcoma/*COMPLICATIONS/PATHOLOGY Mice Mice, Inbred Strains Sarcoma, Kaposi's/*ETIOLOGY/PATHOLOGY ABSTRACTKWDacquiredimmunodeficiencysyndrome/KWDcomplications/pathologyanimalKWDdimethylhydrazineshemangiosarcoma/KWDcomplications/pathologymicemice,inbredstrainssarcoma,kaposi's/KWDetiology/pathologyabstract
931030
M93A0776

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .